- Panaxadiol
-
- $50.00 / 50mg
-
2024-11-19
- CAS:19666-76-3
- Min. Order:
- Purity: 99.9%
- Supply Ability: 10g
- Panaxadiol
-
- $0.00 / 20mg
-
2023-02-24
- CAS:19666-76-3
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- Panaxadiol
-
- $110.00 / 1kg
-
2023-02-13
- CAS:19666-76-3
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 80MT
|
| | Panaxadiol Basic information |
| | Panaxadiol Chemical Properties |
| Melting point | 250℃ | | Boiling point | 531.3±45.0 °C(Predicted) | | density | 1.025±0.06 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | Chloroform (Slightly), Ethyl Acetate (Slightly) | | form | Solid | | pka | 14.82±0.70(Predicted) | | color | White to Off-White | | CAS DataBase Reference | 19666-76-3 |
| Safety Statements | 24/25 | | HS Code | 29329990 |
| | Panaxadiol Usage And Synthesis |
| Chemical Properties | White solid | | Uses | Panaxadiol is the purified sapogenin of ginseng saponins, which exhibits anti-tumor activity. Research has shown Panaxadiol exhibited enhancing activity towards human colorectal cancer cells. | | Definition | ChEBI: Panaxadiol is a triterpenoid saponin. | | in vivo | Panaxadiol (oral gavage; 10 or 30 mg/kg; once every 3 days; 30 d) inhibits the growth of HCT116 cells in a xenograft model[1].
| Animal Model: | BALB/c athymic nude mice injected with HCT116 cells[1] | | Dosage: | 10 or 30 mg/kg | | Administration: | Oral gavage; 10 or 30 mg/kg; once every 3 days; 30 days | | Result: | Inhibited the protein levels of HIF-1α, p-STAT-3 (Tyr705), PD-L1 and VEGF in tumour tissues in a dose-dependent manner. |
|
| | Panaxadiol Preparation Products And Raw materials |
|